|
05 Oct 2007 |
ThromboGenics and Rhein Minapharm Announce Agreement
|
|
04 Oct 2007 |
Peptimmune Initiates Phase I Study With a Novel Peptide Copolymer for the Treatment of Multiple Sclerosis
|
|
04 Oct 2007 |
Roche and Trimeris Provide Update on Development of Alternative Administration Options for Delivery of FUZEON(R)
|
|
04 Oct 2007 |
MacroChem Acquires Rights to Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infections, From Genaera
|
|
04 Oct 2007 |
Protox completes BPH trial recruitment and announces positive interim data
|
|
03 Oct 2007 |
Chemokine Therapeutics Completes Patient Recruitment of CTCE-9908 Phase I/II Clinical Trial
|
|
03 Oct 2007 |
CardioVascular BioTherapeutics Completes Phase I Wound Healing Trial
|
|
02 Oct 2007 |
FDA Approves SYMLIN Pen-Injector Devices Offering Convenience and Accuracy for SYMLIN Use
|
|
02 Oct 2007 |
BioLineRx In-Licenses Novel Peptide BL-4050 for the Treatment of Cancer
|
|
02 Oct 2007 |
Nastech Pharmaceutical Company Announces Initiation of Phase 2 Clinical Trial for PYY3-36 Nasal Spray to Treat Obesity
|
|
28 Sep 2007 |
Amgen Receives Proposal for Amending EU Prescribing Information for Aranesp(R)
|
|
28 Sep 2007 |
Nuvelo Announces Publication of NU206 Study Results in Proceedings of the National Academy of Sciences of the United States of America
|
|
28 Sep 2007 |
Palatin Technologies, Inc. Reports positive data from an at-home study of pre- and postmenopausal women with female sexual arousal disorder treated with bremelanotide
|
|
27 Sep 2007 |
Nycomed and NPS Pharmaceuticals Announce Licensing Agreement for GATTEX(TM)
|
|
27 Sep 2007 |
Phase 2 Study Suggests That Extended Dosing of Aranesp(R) is as Efficacious as Weekly Dosing
|
|
27 Sep 2007 |
Affibody to Start Clinical Development of a New Approach for the Diagnosis of Cancer
|
|
27 Sep 2007 |
Nastech Pharmaceutical Company Announces Initiation of Phase 2 Clinical Trial for Insulin Nasal Spray to Treat Diabetes
|
|
27 Sep 2007 |
Cytheris Expands Interleukin-7 Clinical Development Program With International Phase I/IIa Trial In HIV
|
|
27 Sep 2007 |
New Analysis Suggests First Cycle Use of Neulasta(R) Reduces Febrile Neutropenia Hospitalizations and Chemotherapy Dose Reductions in Breast Cancer Patients Compared to Current Practice
|
|
27 Sep 2007 |
OctoPlus in-licenses diabetes product candidate
|
|
25 Sep 2007 |
Alseres Pharmaceuticals' Announces Expansion of the Cethrin(R) Acute Spinal Cord Injury (SCI) Phase I/IIA Clinical Trial
|
|
25 Sep 2007 |
European Union's CHMP Issues Positive Opinion on PEGINTRON(TM) Combination Therapy for Retreating Hepatitis C Patients Who Failed Previous Therapy
|
|
25 Sep 2007 |
Pacgen Announces Advances in PAC-113 Program
|
|
22 Sep 2007 |
ThromboGenics Completes Enrolment of Patients for the Vitreomacular Traction Trial (MIVI IIT)
|
|
22 Sep 2007 |
Maxygen Announces Hold on MAXY-alpha Development Program
|
